Abu Dhabi, United Arab Emirates – Etihad Cargo, the cargo and logistics arm of Abu Dhabi-based Etihad Aviation Group, has reported a 50 per cent year-on-year rise in pharma shipments under its specialised PharmaLife product.
The double-digit annual growth comes as the carrier marks its second anniversary of achieving and operating IATA CEIV certification for pharmaceutical and life science logistics (IATA CEIV Pharma), in conjunction with its hub at Abu Dhabi International Airport and Etihad Airport Services – one of only 24 such certified carriers worldwide.
Etihad Cargo currently operates across more than 1,050 IATA CEIV Pharma/GDP certified trade lands which ensure the integrity of products during transportation. Driven largely from a demand for both CRT (+15 to +25°C) and COL (+2 to +8°C) segments, Etihad Cargo has also received strong growth for ERT (+2 to +25°C) shipments, launched towards the end of 2020.
“Etihad Cargo has substantial expertise in the global transportation of temperature controlled and time-sensitive pharmaceutical products, including vaccines, operating to stringent manufacturers' requirements,” explained Martin Drew, Senior Vice President Sales and Cargo, Etihad Aviation Group. “The IATA CEIV certification has reaffirmed the carrier’s strength in this sector and strengthened partner trust to deliver a quality product solution across 54 pharma stations with dedicated experts available for advice.”
The launch of the Abu Dhabi-based Hope Consortium towards the end of 2020 has contributed to the end of year increase and is expected to support Etihad Cargo’s pharmaceutical shipment growth through 2021.
“Etihad Cargo’s successful role in the Hope Consortium serves as a significant endorsement of our PharmaLife product, which was the first in the region to attain the IATA CEIV Pharma certification for excellence of product transportation in the sector,” Drew added. “During December millions of doses of the SARS-CoV-2 vaccine were carried on a chartered Etihad Cargo Boeing 777-300ER, with additional shipments scheduled.”
A member of IATA’s Time and Temperature Working Group, Etihad Cargo is planning to boost its global pharma sector credentials through an ongoing education programme which has already reached a worldwide audience of over 600 professionals through 30 webinars.
“This programme will continue throughout 2021 as Etihad Cargo simultaneously builds its network of certified pharmaceutical trade lanes that meet consistent standards and assure product integrity,” added Drew. “Additional enhancements this year include the introduction of thermal blankets, cool dollies and digital e-booking for pharma products, as well as securing co-operation with Pharma.Aero, the powerful cross-industry collaboration for pharma shippers, CEIV certified cargo communities, airport operators and other air cargo industry stakeholders.”
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
